
Oestrogen-sensitive breast cancer, also known as hormone receptor-positive breast cancer, is the most common form of breast cancer. In these cases, the cancer cells have receptors that allow them to use estrogenic to grow. When diagnosed with this condition, one of the key considerations is how certain medications, particularly hormonal contraceptive use, can affect the patient’s treatment and prognosis.
Understanding Oestrogen-Sensitive Breast Cancer
Oestrogen-sensitive breast cancer accounts for about 70-80% of breast cancer cases. The cancer cells respond to the presence of oestrogen, which can stimulate their growth. Treatments for this type of cancer often focus on reducing the body’s oestrogen levels or blocking the cancer cells from utilizing oestrogen.
Hormonal contraceptives, including many birth control pills, patches, and hormonal IUDs, contain synthetic versions of hormones like oestrogen and progesterone, which can potentially fuel the growth of oestrogen-sensitive cancer cells.
Impact of Hormonal Contraceptives on Oestrogen-Sensitive Breast Cancer
1. Increased Risk of Cancer Recurrence
- Oestrogen-containing contraceptives can increase oestrogen levels in the body, potentially stimulating the growth of hormone receptor-positive breast cancer cells.
- Patients with oestrogen-sensitive breast cancer are typically advised to avoid hormonal contraceptives due to the risk of cancer recurrence or progression.
2. Alternatives to Hormonal Birth Control
Women diagnosed with oestrogen-sensitive breast cancer or those at high risk of developing it should consider non-hormonal contraceptive options. Some safer alternatives include:
- Barrier Methods: Condoms, diaphragms, and cervical caps.
- Copper IUD: A non-hormonal intrauterine device that provides long-term contraception without altering hormone levels.
- Sterilization: Surgical options like tubal ligation can provide permanent contraception.
- Natural Family Planning: Tracking ovulation and fertility to avoid pregnancy, although this method has higher failure rates compared to other options.
3. Progesterone-Only Contraceptives
Some patients may be curious about the safety of progesterone-only contraceptives. However, there is limited research on their use in women with hormone-sensitive cancers. While they may be a safer option compared to combined oestrogen-progesterone contraceptives, they are not entirely free of risk. Progesterone can still influence hormone levels, and caution is advised.
Factors to Consider When Choosing a Contraceptive Method
When deciding on a contraceptive method after an oestrogen-sensitive breast cancer diagnosis, the following factors should be considered:
- Risk of Recurrence: Hormonal contraceptives, especially those containing oestrogen, are contraindicated.
- Personal Health History: Patients with a family history of breast cancer should discuss contraceptive options with their GP or a breast surgeon, even if they do not have a diagnosis.
- Lifestyle and Preferences: Some women may prefer non-hormonal methods like barrier methods or copper IUDs due to their low risk of affecting hormone-sensitive conditions.
Frequently Asked Questions (FAQs)
1. Can I use birth control pills after being diagnosed with oestrogen-sensitive breast cancer?
- It is generally not recommended to use birth control pills containing oestrogen after an oestrogen-sensitive breast cancer diagnosis. These pills can increase the level of oestrogen in the body and may promote cancer recurrence.
2. What is the safest contraceptive option for women with oestrogen-sensitive breast cancer?
- Non-hormonal options, such as copper IUDs or barrier methods like condoms and diaphragms, are considered the safest for women with this diagnosis.
3. Are progesterone-only contraceptives safe for women with oestrogen-sensitive breast cancer?
- Progesterone-only contraceptives may be a better option than oestrogen-containing ones, but their safety in women with hormone-sensitive cancers remains uncertain. It’s important to discuss this option with your doctor.
4. Can I use hormonal IUDs if I have oestrogen-sensitive breast cancer?
- Hormonal IUDs release a low dose of hormones, but because they still involve hormone regulation, they are typically not recommended for women with oestrogen-sensitive breast cancer.
5. What about contraceptive implants or injections?
- Hormonal implants and injections, like Depo-Provera, contain synthetic hormones. While some only use progestin, there is still concern about their effect on hormone levels and their safety in women with hormone-sensitive cancers. Non-hormonal methods are generally safer choices.
Conclusion
Women diagnosed with oestrogen-sensitive breast cancer need to carefully consider their contraceptive options due to the potential impact of hormonal methods on cancer progression or recurrence. Non-hormonal alternatives such as copper IUDs, barrier methods, or sterilization offer safer options. Always consult with your oncologist or breast surgeon to determine the best contraceptive method for your unique situation.
Mr Senthurun (Seni) Mylvaganam
Consultant Oncoplastic Breast Surgeon